Literature DB >> 15915617

Population norms and meaningful differences for the Assessment of Quality of Life (AQoL) measure.

Graeme Hawthorne1, Richard Osborne.   

Abstract

OBJECTIVE: The Assessment of Quality of Life (AQoL) instrument is widely used in Australian health research. To assist researchers interpret and report their work, this paper reports population and health status norms, general minimal important differences (MIDs) and effect sizes.
METHOD: Data from the 1998 South Australian Health Omnibus Survey (n=3,010 population-based respondents) were analysed by gender, age group and health status. Data from four other longitudinal studies were analysed to obtain estimated MIDs.
RESULTS: The mean (SD) AQoL utility score was 0.83 (0.20). Gender and age subgroup differences were apparent; the mean scores for women were consistent until their 50s, when scores declined. Greater variability was observed for males whose scores declined more slowly but consistently between 40-80 years. For both genders, those aged 80+ years had the lowest scores. When assessed by health status, those reporting excellent health obtained the highest utility scores; progressive declines were observed with decreasing health status. Effect sizes of 0.13 or greater may reflect important differences between groups. A difference in AQoL scores of 0.06 utility points over time suggests a general MID.
CONCLUSIONS: AQoL population norms, MIDs and effect sizes can be used as reference points for the interpretation of AQoL data. These findings add to the growing evidence that the AQoL is a robust and sensitive measure that has wide applicability. IMPLICATIONS: The availability of population norms will assist researchers using the AQoL to more easily interpret and report their work.

Entities:  

Mesh:

Year:  2005        PMID: 15915617     DOI: 10.1111/j.1467-842x.2005.tb00063.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  86 in total

1.  Economic Analysis of a Three-Arm RCT Exploring the Delivery of Intensive, Prophylactic Swallowing Therapy to Patients with Head and Neck Cancer During (Chemo)Radiotherapy.

Authors:  Laurelie R Wall; Sanjeewa Kularatna; Elizabeth C Ward; Bena Cartmill; Anne J Hill; Elizabeth Isenring; Joshua Byrnes; Sandro V Porceddu
Journal:  Dysphagia       Date:  2018-12-04       Impact factor: 3.438

2.  Vertebroplasty and balloon kyphoplasty in osteoporosis: friends or foes?

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2009-09

3.  Chilean population norms derived from the health-related quality of Life SF-6D.

Authors:  Miguel A Garcia-Gordillo; Daniel Collado-Mateo; Pedro R Olivares; José C Adsuar
Journal:  Eur J Health Econ       Date:  2017-06-19

4.  The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms.

Authors:  Graeme Hawthorne; Richard H Osborne; Anne Taylor; Jan Sansoni
Journal:  Qual Life Res       Date:  2007-02-01       Impact factor: 4.147

5.  Retrospective baseline measurement of self-reported health status and health-related quality of life versus population norms in the evaluation of post-injury losses.

Authors:  W L Watson; J Ozanne-Smith; J Richardson
Journal:  Inj Prev       Date:  2007-02       Impact factor: 2.399

Review 6.  Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension.

Authors:  Hubert Chen; Darren B Taichman; Ramona L Doyle
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

7.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

Review 8.  Evaluation of instruments for measuring the burden of sport and active recreation injury.

Authors:  Nadine E Andrew; Belinda J Gabbe; Rory Wolfe; Peter A Cameron
Journal:  Sports Med       Date:  2010-02-01       Impact factor: 11.136

Review 9.  A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.

Authors:  Hirsch S Ruchlin; Ralph P Insinga
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

10.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.